Check out Dr. Flank's "Hands-on Pharma 3DP" video series!

InfraTrac
InfraTrac
  • Home
  • Solutions
    • Anti-counterfeiting
    • Quality for 3DP
    • Controlled Release
  • About Us
  • News & Events
  • Contact Us
  • Patents & Publications
  • FAQ
  • More
    • Home
    • Solutions
      • Anti-counterfeiting
      • Quality for 3DP
      • Controlled Release
    • About Us
    • News & Events
    • Contact Us
    • Patents & Publications
    • FAQ
  • Home
  • Solutions
    • Anti-counterfeiting
    • Quality for 3DP
    • Controlled Release
  • About Us
  • News & Events
  • Contact Us
  • Patents & Publications
  • FAQ

Quality Assurance for 3D Printing

"Right Drug, Right Dose"

InfraTrac’s near-infrared spectroscopy innovation can ensure that 3D printed drug doses adhere to pharmaceutical quality standards. We have successfully demonstrated that near-infrared (NIR) spectroscopic testing and analysis is capable of distinguishing with high confidence those 3DP doses containing the expected concentrations of active pharmaceutical ingredient (API) and excipient materials from 3D printed tablets (or “printlets”) that do not conform to the standard formulation. 


This capability can provide hospital pharmacies and other point-of-care facilities with a mechanism to protect patients by preventing the inadvertent administration of 3DP doses containing either too much or too little of the prescribed medication. Potential benefits of the quality testing approach validated by the project include that it is non-destructive; rapid to perform; accurate; easy-to-interpret, and inexpensive to implement without the need for extensive retooling or operator training.

Learn More

3D printed drugs are only one of the many use cases where NIR spectroscopy can be used to authenticate a product made by additive manufacturing.  Contact us to discuss your 3DP product protection requirements.

Contact us

Hands-on Pharma 3DP

NIR-based Quality Management

 Right drug, right dose with 3D printing?  InfraTrac CEO Dr. Sharon Flank explains (early, but decisive) 3DP quality monitoring results with NIR spectroscopy, with Keith Freel Ph.D. in Stephen W. Hoag's Applied Pharmaceutics Lab at the University of Maryland School of Pharmacy. 

Predictive Modeling

 InfraTrac is developing predictive modeling that will inform the quality safeguards necessary to make #3Dprinting viable for #pharma, even at the point of care, using the FABRX M3DIMAKER2 3D pharmaceutical printer 

Scaling the Quality Model

 Can we scale? YES!  Not just the #3dprinting with FABRX's M3DIMAKER2 pharmaceutical printer, but the #quality modeling using #spectroscopy, to create an eventual pass-fail #NIR model for good printlets vs. bad printlets.  See the latest InfraTrac and University of Maryland School of Pharmacy progress video to find out how it's going. 

Copyright © 2006-2025 InfraTrac, Inc. - All Rights Reserved.

  • Privacy Policy

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept